MeSH Browser

MeSH Heading: Leukotriene D4
Tree Number(s): D10.251.355.255.100.450.855.461; D10.251.355.310.166.887.855.461; D23.469.050.175.450.725.415
Unique ID: D017998
RDF Unique Identifier: http://id.nlm.nih.gov/mesh/D017998
Scope Note: One of the biologically active principles of SRS-A. It is generated from LEUKOTRIENE C4 after partial hydrolysis of the peptide chain, i.e., cleavage of the gamma-glutamyl portion. Its biological actions include stimulation of vascular and nonvascular smooth muscle, and increases in vascular permeability. (From Dictionary of Prostaglandins and Related Compounds, 1990)
Entry Term(s): LTD4; Leukotriene D; Leukotriene D-4; Leukotrienes D
Registry Number: 73836-78-9
CAS Type 1 Name: Glycine, N-(S-(1-(4-carboxy-1-hydroxybutyl)-2,4,6,9-pentadecatetraenyl)-L-cysteinyl)-, (R-(R*,S*-(E,E,Z,Z)))-
Previous Indexing: SRS-A (1982-1993)
Public MeSH Note: 94; was see SRS-A 1983-93; LEUKOTRIENES D was see SRS-A 1983-93
Online Note: use SRS-A to search LEUKOTRIENE D4 & LEUKOTRIENES D 1983-93
History Note: 94; was see SRS-A 1983-93; LEUKOTRIENES D was see SRS-A 1983-93
Date Established: 1994/01/01
Date of Entry: 1993/06/04
Revision Date: 2015/06/08

Allowable Qualifiers: administration & dosage (AD)

adverse effects (AE)

agonists (AG)

analogs & derivatives (AA)

analysis (AN)

antagonists & inhibitors (AI)

biosynthesis (BI)

blood (BL)

cerebrospinal fluid (CF)

chemical synthesis (CS)

chemistry (CH)

classification (CL)

deficiency (DF)

economics (EC)

genetics (GE)

history (HI)

immunology (IM)

isolation & purification (IP)

metabolism (ME)

pharmacokinetics (PK)

pharmacology (PD)

physiology (PH)

poisoning (PO)

radiation effects (RE)

standards (ST)

supply & distribution (SD)

therapeutic use (TU)

toxicity (TO)

urine (UR)

Concept UI: M0027179
Registry Number: 73836-78-9
Scope Note: One of the biologically active principles of SRS-A. It is generated from LEUKOTRIENE C4 after partial hydrolysis of the peptide chain, i.e., cleavage of the gamma-glutamyl portion. Its biological actions include stimulation of vascular and nonvascular smooth muscle, and increases in vascular permeability. (From Dictionary of Prostaglandins and Related Compounds, 1990)
Terms: Leukotriene D4 Preferred Term
Term UI T053792
Date01/01/1999
LexicalTag NON
ThesaurusID NLM (1994); Leukotriene D-4
Term UI T053794
Date03/22/1993
LexicalTag NON
ThesaurusID NLM (1994); LTD4
Term UI T053793
Date03/22/1993
LexicalTag ABB
ThesaurusID NLM (1994)

Leukotriene D4 MeSH Descriptor Data 2023